Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Targeting the glutamatergic system to counteract organophosphate poisoning: A novel therapeutic strategy.

Aroniadou-Anderjaska V, Figueiredo TH, Apland JP, Braga MF.

Neurobiol Dis. 2019 Feb 21:104406. doi: 10.1016/j.nbd.2019.02.017. [Epub ahead of print] Review.

2.

Full Protection Against Soman-Induced Seizures and Brain Damage by LY293558 and Caramiphen Combination Treatment in Adult Rats.

Apland JP, Aroniadou-Anderjaska V, Figueiredo TH, De Araujo Furtado M, Braga MFM.

Neurotox Res. 2018 Oct;34(3):511-524. doi: 10.1007/s12640-018-9907-1. Epub 2018 Apr 30.

PMID:
29713995
3.

Comparing the Antiseizure and Neuroprotective Efficacy of LY293558, Diazepam, Caramiphen, and LY293558-Caramiphen Combination against Soman in a Rat Model Relevant to the Pediatric Population.

Apland JP, Aroniadou-Anderjaska V, Figueiredo TH, Pidoplichko VI, Rossetti K, Braga MFM.

J Pharmacol Exp Ther. 2018 May;365(2):314-326. doi: 10.1124/jpet.117.245969. Epub 2018 Feb 21.

4.

Oscillatory Synchronous Inhibition in the Basolateral Amygdala and its Primary Dependence on NR2A-containing NMDA Receptors.

Aroniadou-Anderjaska V, Pidoplichko VI, Figueiredo TH, Braga MFM.

Neuroscience. 2018 Mar 1;373:145-158. doi: 10.1016/j.neuroscience.2018.01.021. Epub 2018 Jan 13.

PMID:
29339324
5.

Susceptibility to Soman Toxicity and Efficacy of LY293558 Against Soman-Induced Seizures and Neuropathology in 10-Month-Old Male Rats.

Apland JP, Aroniadou-Anderjaska V, Figueiredo TH, Prager EM, Olsen CH, Braga MFM.

Neurotox Res. 2017 Nov;32(4):694-706. doi: 10.1007/s12640-017-9789-7. Epub 2017 Aug 3.

PMID:
28776308
6.

The M1 Muscarinic Receptor Antagonist VU0255035 Delays the Development of Status Epilepticus after Organophosphate Exposure and Prevents Hyperexcitability in the Basolateral Amygdala.

Miller SL, Aroniadou-Anderjaska V, Pidoplichko VI, Figueiredo TH, Apland JP, Krishnan JK, Braga MF.

J Pharmacol Exp Ther. 2017 Jan;360(1):23-32. Epub 2016 Oct 31.

7.

Repeated Isoflurane Exposures Impair Long-Term Potentiation and Increase Basal GABAergic Activity in the Basolateral Amygdala.

Long Ii RP, Aroniadou-Anderjaska V, Prager EM, Pidoplichko VI, Figueiredo TH, Braga MF.

Neural Plast. 2016;2016:8524560. doi: 10.1155/2016/8524560. Epub 2016 May 23.

8.

Long-term neuropathological and behavioral impairments after exposure to nerve agents.

Aroniadou-Anderjaska V, Figueiredo TH, Apland JP, Prager EM, Pidoplichko VI, Miller SL, Braga MF.

Ann N Y Acad Sci. 2016 Jun;1374(1):17-28. doi: 10.1111/nyas.13028. Epub 2016 Mar 22. Review.

9.

A rat model of nerve agent exposure applicable to the pediatric population: The anticonvulsant efficacies of atropine and GluK1 antagonists.

Miller SL, Aroniadou-Anderjaska V, Figueiredo TH, Prager EM, Almeida-Suhett CP, Apland JP, Braga MF.

Toxicol Appl Pharmacol. 2015 Apr 15;284(2):204-16. doi: 10.1016/j.taap.2015.02.008. Epub 2015 Feb 15.

10.

LY293558 prevents soman-induced pathophysiological alterations in the basolateral amygdala and the development of anxiety.

Prager EM, Figueiredo TH, Long RP 2nd, Aroniadou-Anderjaska V, Apland JP, Braga MF.

Neuropharmacology. 2015 Feb;89:11-8. doi: 10.1016/j.neuropharm.2014.08.014. Epub 2014 Sep 6.

11.

The limitations of diazepam as a treatment for nerve agent-induced seizures and neuropathology in rats: comparison with UBP302.

Apland JP, Aroniadou-Anderjaska V, Figueiredo TH, Rossetti F, Miller SL, Braga MF.

J Pharmacol Exp Ther. 2014 Nov;351(2):359-72. doi: 10.1124/jpet.114.217299. Epub 2014 Aug 25.

12.

Pathophysiological mechanisms underlying increased anxiety after soman exposure: reduced GABAergic inhibition in the basolateral amygdala.

Prager EM, Pidoplichko VI, Aroniadou-Anderjaska V, Apland JP, Braga MF.

Neurotoxicology. 2014 Sep;44:335-43. doi: 10.1016/j.neuro.2014.08.007. Epub 2014 Aug 20.

13.

ASIC1a activation enhances inhibition in the basolateral amygdala and reduces anxiety.

Pidoplichko VI, Aroniadou-Anderjaska V, Prager EM, Figueiredo TH, Almeida-Suhett CP, Miller SL, Braga MF.

J Neurosci. 2014 Feb 26;34(9):3130-41. doi: 10.1523/JNEUROSCI.4009-13.2014.

14.

The recovery of acetylcholinesterase activity and the progression of neuropathological and pathophysiological alterations in the rat basolateral amygdala after soman-induced status epilepticus: relation to anxiety-like behavior.

Prager EM, Aroniadou-Anderjaska V, Almeida-Suhett CP, Figueiredo TH, Apland JP, Rossetti F, Olsen CH, Braga MF.

Neuropharmacology. 2014 Jun;81:64-74. doi: 10.1016/j.neuropharm.2014.01.035. Epub 2014 Jan 31.

15.

α7-Containing nicotinic acetylcholine receptors on interneurons of the basolateral amygdala and their role in the regulation of the network excitability.

Pidoplichko VI, Prager EM, Aroniadou-Anderjaska V, Braga MF.

J Neurophysiol. 2013 Nov;110(10):2358-69. doi: 10.1152/jn.01030.2012. Epub 2013 Sep 4.

16.

Acetylcholinesterase inhibition in the basolateral amygdala plays a key role in the induction of status epilepticus after soman exposure.

Prager EM, Aroniadou-Anderjaska V, Almeida-Suhett CP, Figueiredo TH, Apland JP, Braga MF.

Neurotoxicology. 2013 Sep;38:84-90. doi: 10.1016/j.neuro.2013.06.006. Epub 2013 Jun 29.

PMID:
23817175
17.

Efficacy of the GluK1/AMPA receptor antagonist LY293558 against seizures and neuropathology in a soman-exposure model without pretreatment and its pharmacokinetics after intramuscular administration.

Apland JP, Aroniadou-Anderjaska V, Figueiredo TH, Green CE, Swezey R, Yang C, Qashu F, Braga MF.

J Pharmacol Exp Ther. 2013 Jan;344(1):133-40. doi: 10.1124/jpet.112.198689. Epub 2012 Oct 5.

18.

Presynaptic facilitation of glutamate release in the basolateral amygdala: a mechanism for the anxiogenic and seizurogenic function of GluK1 receptors.

Aroniadou-Anderjaska V, Pidoplichko VI, Figueiredo TH, Almeida-Suhett CP, Prager EM, Braga MF.

Neuroscience. 2012 Sep 27;221:157-69. doi: 10.1016/j.neuroscience.2012.07.006. Epub 2012 Jul 13.

19.

Neuroprotective efficacy of caramiphen against soman and mechanisms of its action.

Figueiredo TH, Aroniadou-Anderjaska V, Qashu F, Apland JP, Pidoplichko V, Stevens D, Ferrara TM, Braga MF.

Br J Pharmacol. 2011 Nov;164(5):1495-505. doi: 10.1111/j.1476-5381.2011.01427.x.

20.

RDX binds to the GABA(A) receptor-convulsant site and blocks GABA(A) receptor-mediated currents in the amygdala: a mechanism for RDX-induced seizures.

Williams LR, Aroniadou-Anderjaska V, Qashu F, Finne H, Pidoplichko V, Bannon DI, Braga MF.

Environ Health Perspect. 2011 Mar;119(3):357-63. doi: 10.1289/ehp.1002588. Erratum in: Environ Health Perspect. 2013 May;121(5):A146.

21.

The GluK1 (GluR5) Kainate/{alpha}-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist LY293558 reduces soman-induced seizures and neuropathology.

Figueiredo TH, Qashu F, Apland JP, Aroniadou-Anderjaska V, Souza AP, Braga MF.

J Pharmacol Exp Ther. 2011 Feb;336(2):303-12. doi: 10.1124/jpet.110.171835. Epub 2010 Oct 20.

22.

Higher susceptibility of the ventral versus the dorsal hippocampus and the posteroventral versus anterodorsal amygdala to soman-induced neuropathology.

Apland JP, Figueiredo TH, Qashu F, Aroniadou-Anderjaska V, Souza AP, Braga MF.

Neurotoxicology. 2010 Sep;31(5):485-92. doi: 10.1016/j.neuro.2010.05.014. Epub 2010 Jun 8.

23.

Electroconvulsive shocks exacerbate the heightened acoustic startle response in stressed rats.

Manion ST, Figueiredo TH, Aroniadou-Anderjaska V, Braga MFM.

Behav Neurosci. 2010 Feb;124(1):170-174. doi: 10.1037/a0018258.

PMID:
20141293
24.

Primary brain targets of nerve agents: the role of the amygdala in comparison to the hippocampus.

Aroniadou-Anderjaska V, Figueiredo TH, Apland JP, Qashu F, Braga MF.

Neurotoxicology. 2009 Sep;30(5):772-6. doi: 10.1016/j.neuro.2009.06.011. Epub 2009 Jul 8.

25.

Pathological alterations in GABAergic interneurons and reduced tonic inhibition in the basolateral amygdala during epileptogenesis.

Fritsch B, Qashu F, Figueiredo TH, Aroniadou-Anderjaska V, Rogawski MA, Braga MF.

Neuroscience. 2009 Sep 29;163(1):415-29. doi: 10.1016/j.neuroscience.2009.06.034. Epub 2009 Jun 18.

26.

Topiramate reduces excitability in the basolateral amygdala by selectively inhibiting GluK1 (GluR5) kainate receptors on interneurons and positively modulating GABAA receptors on principal neurons.

Braga MF, Aroniadou-Anderjaska V, Li H, Rogawski MA.

J Pharmacol Exp Ther. 2009 Aug;330(2):558-66. doi: 10.1124/jpet.109.153908. Epub 2009 May 5.

PMID:
19417176
27.

Soman induces ictogenesis in the amygdala and interictal activity in the hippocampus that are blocked by a GluR5 kainate receptor antagonist in vitro.

Apland JP, Aroniadou-Anderjaska V, Braga MF.

Neuroscience. 2009 Mar 3;159(1):380-9. doi: 10.1016/j.neuroscience.2008.11.053. Epub 2008 Dec 14.

28.

Diazepam administration after prolonged status epilepticus reduces neurodegeneration in the amygdala but not in the hippocampus during epileptogenesis.

Qashu F, Figueiredo TH, Aroniadou-Anderjaska V, Apland JP, Braga MF.

Amino Acids. 2010 Jan;38(1):189-97. doi: 10.1007/s00726-008-0227-2. Epub 2009 Jan 7.

29.

Pathology and pathophysiology of the amygdala in epileptogenesis and epilepsy.

Aroniadou-Anderjaska V, Fritsch B, Qashu F, Braga MF.

Epilepsy Res. 2008 Feb;78(2-3):102-16. doi: 10.1016/j.eplepsyres.2007.11.011. Epub 2008 Jan 15. Review.

30.

Mechanisms regulating GABAergic inhibitory transmission in the basolateral amygdala: implications for epilepsy and anxiety disorders.

Aroniadou-Anderjaska V, Qashu F, Braga MF.

Amino Acids. 2007;32(3):305-15. Epub 2006 Oct 18. Review.

PMID:
17048126
31.

The physiological role of kainate receptors in the amygdala.

Braga MF, Aroniadou-Anderjaska V, Li H.

Mol Neurobiol. 2004 Oct;30(2):127-41. Review.

PMID:
15475623
32.

Stress impairs alpha(1A) adrenoceptor-mediated noradrenergic facilitation of GABAergic transmission in the basolateral amygdala.

Braga MF, Aroniadou-Anderjaska V, Manion ST, Hough CJ, Li H.

Neuropsychopharmacology. 2004 Jan;29(1):45-58.

33.
35.

Dopamine D2 receptor-mediated presynaptic inhibition of olfactory nerve terminals.

Ennis M, Zhou FM, Ciombor KJ, Aroniadou-Anderjaska V, Hayar A, Borrelli E, Zimmer LA, Margolis F, Shipley MT.

J Neurophysiol. 2001 Dec;86(6):2986-97.

36.

Input-specific LTP and depotentiation in the basolateral amygdala.

Aroniadou-Anderjaska V, Post RM, Rogawski MA, Li H.

Neuroreport. 2001 Mar 5;12(3):635-40.

PMID:
11234779
37.

Tonic and synaptically evoked presynaptic inhibition of sensory input to the rat olfactory bulb via GABA(B) heteroreceptors.

Aroniadou-Anderjaska V, Zhou FM, Priest CA, Ennis M, Shipley MT.

J Neurophysiol. 2000 Sep;84(3):1194-203.

38.

Dendrodendritic recurrent excitation in mitral cells of the rat olfactory bulb.

Aroniadou-Anderjaska V, Ennis M, Shipley MT.

J Neurophysiol. 1999 Jul;82(1):489-94.

39.

Glutamate and synaptic plasticity at mammalian primary olfactory synapses.

Ennis M, Linster C, Aroniadou-Anderjaska V, Ciombor K, Shipley MT.

Ann N Y Acad Sci. 1998 Nov 30;855:457-66.

PMID:
9929639
40.
41.

Functional organization of rat olfactory bulb glomeruli revealed by optical imaging.

Keller A, Yagodin S, Aroniadou-Anderjaska V, Zimmer LA, Ennis M, Sheppard NF Jr, Shipley MT.

J Neurosci. 1998 Apr 1;18(7):2602-12.

42.

Glomerular synaptic responses to olfactory nerve input in rat olfactory bulb slices.

Aroniadou-Anderjaska V, Ennis M, Shipley MT.

Neuroscience. 1997 Jul;79(2):425-34.

PMID:
9200726
43.

Effects of exogenous growth hormone on skeletal muscle of young female rats.

Aroniadou-Anderjaska V, Lemon PW, Gilloteaux J.

Tissue Cell. 1996 Dec;28(6):719-24.

PMID:
9004537
44.

Intrinsic inhibitory pathways in mouse barrel cortex.

Aroniadou-Anderjaska V, Keller A.

Neuroreport. 1996 Oct 2;7(14):2363-8.

PMID:
8951853
45.

LTP in the barrel cortex of adult rats.

Aroniadou-Anderjaska V, Keller A.

Neuroreport. 1995 Nov 27;6(17):2297-300.

PMID:
8747140

Supplemental Content

Loading ...
Support Center